Entrez Id: |
3458 |
Gene Symbol: |
IFNG |
IFNG
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.
|
25099164 |
2014 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
|
21428768 |
2011 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Genetic and ethnic risk factors associated with drug hypersensitivity.
|
20485159 |
2010 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians.
|
19915237 |
2010 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.
|
19694795 |
2010 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
|
20235791 |
2010 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.
|
18855540 |
2008 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
|
16538176 |
2006 |
Entrez Id: |
3106 |
Gene Symbol: |
HLA-B |
HLA-B
|
Drug-Induced Stevens Johnson Syndrome
|
0.310 |
Biomarker |
CTD_human |
Medical genetics: a marker for Stevens-Johnson syndrome.
|
15057820 |
2004 |
Entrez Id: |
2033 |
Gene Symbol: |
EP300 |
EP300
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
857 |
Gene Symbol: |
CAV1 |
CAV1
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
10659 |
Gene Symbol: |
CELF2 |
CELF2
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
142 |
Gene Symbol: |
PARP1 |
PARP1
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
8454 |
Gene Symbol: |
CUL1 |
CUL1
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
5740 |
Gene Symbol: |
PTGIS |
PTGIS
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
79139 |
Gene Symbol: |
DERL1 |
DERL1
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
5371 |
Gene Symbol: |
PML |
PML
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
10987 |
Gene Symbol: |
COPS5 |
COPS5
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
7415 |
Gene Symbol: |
VCP |
VCP
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
5705 |
Gene Symbol: |
PSMC5 |
PSMC5
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
9844 |
Gene Symbol: |
ELMO1 |
ELMO1
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
1499 |
Gene Symbol: |
CTNNB1 |
CTNNB1
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
8451 |
Gene Symbol: |
CUL4A |
CUL4A
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Entrez Id: |
26270 |
Gene Symbol: |
FBXO6 |
FBXO6
|
Drug-Induced Stevens Johnson Syndrome
|
0.300 |
Biomarker |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |